Literature DB >> 26581673

The long-term effects of methamphetamine exposure during pre-adolescence on depressive-like behaviour in a genetic animal model of depression.

Moné Mouton1, Brian H Harvey1, Marike Cockeran2, Christiaan B Brink3.   

Abstract

Methamphetamine (METH) is a psychostimulant and drug of abuse, commonly used early in life, including in childhood and adolescence. Adverse effects include psychosis, anxiety and mood disorders, as well as increased risk of developing a mental disorder later in life. The current study investigated the long-term effects of chronic METH exposure during pre-adolescence in stress-sensitive Flinders Sensitive Line (FSL) rats (genetic model of depression) and control Flinders Resistant Line (FRL) rats. METH or vehicle control was administered twice daily from post-natal day 19 (PostND19) to PostND34, followed by behavioural testing at either PostND35 (early effects) or long-lasting after withdrawal at PostND60 (early adulthood). Animals were evaluated for depressive-like behaviour, locomotor activity, social interaction and object recognition memory. METH reduced depressive-like behaviour in both FSL and FRL rats at PostND35, but enhanced this behaviour at PostND60. METH also reduced locomotor activity on PostND35 in both FSL and FRL rats, but without effect at PostND60. Furthermore, METH significantly lowered social interaction behaviour (staying together) in both FRL and FSL rats at PostND35 and PostND60, whereas self-grooming time was significantly reduced only at PostND35. METH treatment enhanced exploration of the familiar vs. novel object in the novel object recognition test (nORT) in FSL and FRL rats on PostND35 and PostND60, indicative of reduced cognitive performance. Thus, early-life METH exposure induce social and cognitive deficits. Lastly, early-life exposure to METH may result in acute antidepressant-like effects immediately after chronic exposure, whereas long-term effects after withdrawal are depressogenic. Data also supports a role for genetic predisposition as with FSL rats.

Entities:  

Keywords:  Depression; Early-life exposure; Finders Sensitive Line; Flinders Resistant Line; Methamphetamine

Mesh:

Substances:

Year:  2015        PMID: 26581673     DOI: 10.1007/s11011-015-9765-y

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  40 in total

Review 1.  A review of the clinical pharmacology of methamphetamine.

Authors:  Christopher C Cruickshank; Kyle R Dyer
Journal:  Addiction       Date:  2009-04-29       Impact factor: 6.526

Review 2.  The Flinders Sensitive Line rat: a selectively bred putative animal model of depression.

Authors:  David H Overstreet; Elliot Friedman; Aleksander A Mathé; Gal Yadid
Journal:  Neurosci Biobehav Rev       Date:  2005-04-22       Impact factor: 8.989

Review 3.  Neurodevelopmental origins of depressive disorders.

Authors:  Mark S Ansorge; René Hen; Jay A Gingrich
Journal:  Curr Opin Pharmacol       Date:  2006-12-21       Impact factor: 5.547

4.  Reduced anxiety-- and depression-like behaviors in Emx1 homozygous mutant mice.

Authors:  Bo-Jin Cao; Yuqing Li
Journal:  Brain Res       Date:  2002-05-24       Impact factor: 3.252

5.  A retrospective review of trends and clinical characteristics of methamphetamine-related acute psychiatric admissions in a South African context.

Authors:  P J Vos; K J Cloete; A le Roux; M Kidd; G P Jordaan
Journal:  Afr J Psychiatry (Johannesbg)       Date:  2010-11

6.  Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.

Authors:  Zahra Alam Mehrjerdi; Zohreh Abarashi; Alireza Noroozi; Leila Arshad; Mehran Zarghami
Journal:  Int J STD AIDS       Date:  2013-11-28       Impact factor: 1.359

Review 7.  The flinders sensitive line rat model of depression--25 years and still producing.

Authors:  David H Overstreet; Gregers Wegener
Journal:  Pharmacol Rev       Date:  2013-01-10       Impact factor: 25.468

Review 8.  The effects of adolescent methamphetamine exposure.

Authors:  Jordan M Buck; Jessica A Siegel
Journal:  Front Neurosci       Date:  2015-04-29       Impact factor: 4.677

Review 9.  Role of early life exposure and environment on neurodegeneration: implications on brain disorders.

Authors:  Shweta Modgil; Debomoy K Lahiri; Vijay L Sharma; Akshay Anand
Journal:  Transl Neurodegener       Date:  2014-04-29       Impact factor: 8.014

Review 10.  Involvement of genetic and environmental factors in the onset of depression.

Authors:  Toshitaka Nabeshima; Hyoung-Chun Kim
Journal:  Exp Neurobiol       Date:  2013-12-31       Impact factor: 3.261

View more
  5 in total

Review 1.  Peri-adolescent exposure to (meth)amphetamine in animal models.

Authors:  T J Phillips; S J Aldrich
Journal:  Int Rev Neurobiol       Date:  2021-08-20       Impact factor: 4.280

2.  N-acetyl cysteine reverses bio-behavioural changes induced by prenatal inflammation, adolescent methamphetamine exposure and combined challenges.

Authors:  Twanette Swanepoel; Marisa Möller; Brian Herbert Harvey
Journal:  Psychopharmacology (Berl)       Date:  2017-11-08       Impact factor: 4.530

3.  Methamphetamine exposure and its cessation alter gut microbiota and induce depressive-like behavioral effects on rats.

Authors:  Shadab Forouzan; Kristi L Hoffman; Therese A Kosten
Journal:  Psychopharmacology (Berl)       Date:  2020-10-23       Impact factor: 4.530

4.  Beyond Emotional and Spatial Processes: Cognitive Dysfunction in a Depressive Phenotype Produced by Long Photoperiod Exposure.

Authors:  Abigail K Barnes; Summer B Smith; Subimal Datta
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

5.  Does Repeated Methamphetamine Exposure at Different Regimens Cause Parkinsonian-Like Behavior in Rats?

Authors:  Neda Valian; Abolhassan Ahmadiani; Leila Dargahi
Journal:  Iran J Pharm Res       Date:  2018       Impact factor: 1.696

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.